Read the Journal of Managed Care + Specialty Pharmacy (JMCP) March 2025 Issue
AMCP Submits Comments to CMS on Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency
The Academy of Managed Care Pharmacy (AMCP) is pleased provide comments to the Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule “Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency [CMS-4187-P]” published in the Federal Register on October 18, 2018. AMCP appreciates the opportunity to leverage our members’ expertise in offering feedback on this proposed rule and we look forward to continued dialogue with CMS on ways to improve drug price transparency and make medications more affordable for patients.
Related
View our Market Insights webinar that features an enlightening exploration of the intersection between mental health and rare diseases.
Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
